News about Global Pharma

DoKaSch Expands Global Presence with New Depot in Dubai

The strategic move strengthens the company's presence in the Middle East and enhances its global network, says an official release.

Global Pharma | 27/11/2023 | By Manvi |  1201

Lupin Receives Approval from US FDA for Bromfenac Ophthalmic Solution, 0.07%

Lupin is the exclusive first-to-file for this product and is eligible for 180-day exclusivity. The product will be manufactured at Lupin’s Pithampur facility in India.

Global Pharma | 27/11/2023 | By Manvi |  724

Pharma Posts End of Year Bounce as CPHI Barcelona Reports Record Attendance

CPHI Barcelona hosted last month in Spain saw a record attendance of 54,000 as pharma confidence returns. The exhibition, which is seen by many as an early indicator of growth in the year ahead, points to the industry having turned a corner with demand expected to accelerate in 2024.

Global Pharma | 27/11/2023 | By Manvi |  484

Strides Gets USFDA Approval for Generic Suprep Bowel Prep Kit

The Product has a market size of USD143 Mn per IQVIA. The Product will be manufactured at the company's facility in Bengaluru.

Global Pharma | 27/11/2023 | By Manvi |  987

Symbiosis Pharmaceutical Services granted MHRA Licence Following 1Mn Pound Investment

Symbiosis Pharmaceutical Services, has launched new in-house analytical and microbiological capabilities to enable testing of small molecule, biological, and Advanced Therapeutic Medicinal Products (ATMP) biopharmaceuticals following a £1m plus investment.

Global Pharma | 23/11/2023 | By Manvi |  876

AstraZeneca Pharma Gets Permission to Import Pharmaceutical Formulations of New Drug for Sale

AstraZeneca Pharma India Limited has received permission to import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for the additional indication of Olaparib film coated tablets of 100mg / 150mg (Lynparza).

Global Pharma | 23/11/2023 | By Manvi |  617

Chiesi and Haisco Announce Licensing Agreement

HSK31858 is an oral, potent, and highly selective small molecule DPP1 inhibitor currently in Phase 2 trials in China with the potential to be an anti-inflammatory agent in bronchiectasis.

Global Pharma | 22/11/2023 | By Manvi |  1028

USFDA Gives Nod to Strides Pharma's Generic Drug for Seizures

Strides Pharma Science announced that its subsidiary has received approval from the US health regulator to market a generic medication for seizures.

Global Pharma | 22/11/2023 | By Manvi |  490

CPHI & PMEC India Expo Returns with Renewed Vision for the Pharmaceutical Landscape

As the largest and most exhaustive pharmaceutical industry event in South Asia, this signature expo is slated to unfold from November 28th to November 30th, 2023, at the India Expo Centre in Greater Noida, Delhi.

Global Pharma | 20/11/2023 | By Manvi |  957

ACG Engineering Launches SMARTCOATER X ONE Series

ACG Engineering has launched its new SMARTCOATER X•ONE series, the company’s fastest tablet coater to date.

Global Pharma | 20/11/2023 | By Manvi |  649